Quantitative susceptibility mapping (QSM) and R2* in the human brain at 3T: Evaluation of intra-scanner repeatability.

Quantitative susceptibility mapping (QSM) and the effective transverse relaxation rate (R2*) can be used to monitor iron and myelin content in brain tissue, which are both subject to changes in many neurological diseases but also during healthy aging. In this study, we quantitatively assessed the repeatability of QSM and R2* by applying four independent scans in eight young healthy, female subjects on a 3T MRI scanner. Since QSM does not yield absolute values for bulk magnetic susceptibilities, we additionally investigated the influence of the choice of a reference brain region for susceptibility by computing susceptibility differences with respect to five different brain structures (whole brain, frontal white matter (fWM), internal capsule (IC), cerebrospinal fluid (CSF) in the lateral ventricle, cortical gray matter (cGM)). The intra-class correlation coefficient (ICC), variance ratio (VR) and repeatability coefficient (RC) were used to evaluate the repeatability of the calculated susceptibility differences and the R2* values in six different subcortical brain structures. Linear regression was used to analyze the correlation between susceptibility differences and R2*. We found that the susceptibility differences with respect to each investigated reference region (0.868≤mean ICC≤0.914) and the R2* values (mean ICC=0.923) were highly repeatable across the four times repeated scans. With consistently higher ICC, higher VR and lower RC, whole brain and cGM appeared to be the two most suitable reference regions for QSM with respect to repeatability.

[1]  Oliver Bieri,et al.  Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI , 2016, PloS one.

[2]  Ferdinand Schweser,et al.  Overview of quantitative susceptibility mapping , 2017, NMR in biomedicine.

[3]  Margit Jehna,et al.  Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.

[4]  Tsutomu Okada,et al.  Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility , 2015, Investigative radiology.

[5]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[6]  Ferdinand Schweser,et al.  Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). , 2016, Zeitschrift fur medizinische Physik.

[7]  Aaron J. Miller,et al.  The use of power images to perform quantitative analysis on low SNR MR images. , 1993, Magnetic resonance imaging.

[8]  Xue Xiao,et al.  Integrated Laplacian‐based phase unwrapping and background phase removal for quantitative susceptibility mapping , 2014, NMR in biomedicine.

[9]  Wei Li,et al.  Susceptibility‐weighted imaging and quantitative susceptibility mapping in the brain , 2015, Journal of magnetic resonance imaging : JMRI.

[10]  Huiman X Barnhart,et al.  Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets. , 2009, Translational oncology.

[11]  D. Yablonskiy,et al.  Biophysical mechanisms of phase contrast in gradient echo MRI , 2009, Proceedings of the National Academy of Sciences.

[12]  Christian Langkammer,et al.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.

[13]  Jian-Qiang Lu,et al.  Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter , 2015, NeuroImage.

[14]  Julie C Stout,et al.  Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  Bing Wu,et al.  Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings , 2012, NeuroImage.

[16]  Pascal Spincemaille,et al.  Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) using quantitative susceptibility mapping (QSM) , 2015, Magnetic resonance in medicine.

[17]  Mark E Ladd,et al.  Suitable reference tissues for quantitative susceptibility mapping of the brain , 2017, Magnetic resonance in medicine.

[18]  Agostinho Santos,et al.  ioinorganic chemistry ron levels in the human brain : A post-mortem study of anatomical egion differences and age-related changes , 2013 .

[19]  Susumu Mori,et al.  Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: Application to determine iron content in deep gray matter structures , 2013, NeuroImage.

[20]  Richard Bowtell,et al.  Effects of White Matter Microstructure on Phase and Susceptibility Maps , 2014, Magnetic resonance in medicine.

[21]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[22]  P-Y Lin,et al.  Quantitative Susceptibility Mapping of Human Brain at 3T: A Multisite Reproducibility Study , 2015, American Journal of Neuroradiology.

[23]  Pascal Spincemaille,et al.  Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors , 2015, Journal of magnetic resonance imaging : JMRI.

[24]  Bruce R. Rosen,et al.  Regional quantification of cerebral venous oxygenation from MRI susceptibility during hypercapnia , 2015, NeuroImage.

[25]  Leslie G. Portney Dpt PhD Fapta,et al.  Foundations of Clinical Research: Applications to Practice , 2015 .

[26]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[27]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain , 2012, NeuroImage.

[28]  E Mark Haacke,et al.  Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.

[29]  Bing Wu,et al.  Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals , 2012, NeuroImage.

[30]  W R Kinkel,et al.  Changes in size of normal lateral ventricles during aging determined by computerized tomography , 1976, Neurology.

[31]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[32]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[33]  E. Haacke,et al.  Quantitative susceptibility mapping: current status and future directions. , 2015, Magnetic resonance imaging.

[34]  Eero P. Simoncelli,et al.  Image quality assessment: from error visibility to structural similarity , 2004, IEEE Transactions on Image Processing.

[35]  Bing Wu,et al.  High-field (9.4T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility , 2011, NeuroImage.

[36]  Dana Cobzas,et al.  Subcortical gray matter segmentation and voxel‐based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis , 2015, Journal of magnetic resonance imaging : JMRI.

[37]  Ferdinand Schweser,et al.  SHARP edges: Recovering cortical phase contrast through harmonic extension , 2015, Magnetic resonance in medicine.

[38]  Robert Turner,et al.  Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.

[39]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[40]  A Yagishita,et al.  Location of the corticospinal tract in the internal capsule at MR imaging. , 1994, Radiology.

[41]  Robert Turner,et al.  High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla , 2013, Front. Hum. Neurosci..

[42]  Mithat Gönen,et al.  Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.

[43]  Yi Ai,et al.  Correlation of R2 with total iron concentration in the brains of rhesus monkeys , 2005, Journal of magnetic resonance imaging : JMRI.

[44]  Saurabh Guleria,et al.  Myelin, myelination, and corresponding magnetic resonance imaging changes. , 2014, Radiologic clinics of North America.

[45]  Ferdinand Schweser,et al.  A comprehensive numerical analysis of background phase correction with V‐SHARP , 2017, NMR in biomedicine.

[46]  Rolf Gruetter,et al.  Studying cyto and myeloarchitecture of the human cortex at ultra-high field with quantitative imaging: R1, R2 * and magnetic susceptibility , 2017, NeuroImage.

[47]  A H Wilman,et al.  Structural and functional quantitative susceptibility mapping from standard fMRI studies , 2017, NMR in biomedicine.

[48]  Yu-Chung N. Cheng,et al.  Limitations of calculating field distributions and magnetic susceptibilities in MRI using a Fourier based method , 2009, Physics in medicine and biology.

[49]  Yi Wang,et al.  Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.

[50]  Hongfu Sun,et al.  Quantitative susceptibility mapping using a superposed dipole inversion method: Application to intracranial hemorrhage , 2016, Magnetic resonance in medicine.

[51]  J. Reichenbach,et al.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.

[52]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[53]  D. Cicchetti Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. , 1994 .

[54]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.

[55]  Tian Liu,et al.  Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages , 2016, Journal of magnetic resonance imaging : JMRI.

[56]  C. Morris,et al.  Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.

[57]  R. Ordidge,et al.  Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla , 1994, Magnetic resonance in medicine.

[58]  S. Lehéricy,et al.  Reproducibility of R2* and quantitative susceptibility mapping (QSM) reconstruction methods in the basal ganglia of healthy subjects , 2017, NMR in biomedicine.

[59]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.

[60]  Guy B. Williams,et al.  In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease , 2013, PloS one.

[61]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping in Parkinson's Disease , 2016, PloS one.

[62]  J. R. Reichenbach,et al.  Quantitative Susceptibility Mapping: Concepts and Applications , 2015, Clinical Neuroradiology.

[63]  Klaus Scheffler,et al.  Functional quantitative susceptibility mapping (fQSM) , 2012, NeuroImage.

[64]  Tian Liu,et al.  Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. , 2013, Radiology.

[65]  M. Fukunaga,et al.  Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast , 2010, Proceedings of the National Academy of Sciences.

[66]  Frédérique Frouin,et al.  An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). , 2017, Magnetic resonance imaging.